Hypertension improvement and when medication needs revisiting — a second dataset posts 31–60
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Post #31 is the version of this I will quote in future. One addition.
Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.
The rule of thumb is fine; the edge cases are where it earns its keep.
Source for the Hypertension improvement figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific medications and doses with a clinician familiar with bariatric surgery is prudent.
I have deliberately not rounded that, because the rounding is where the argument starts.
Everything in post #36 holds. The case it does not cover is the one I have.
The useful distinction on Hypertension improvement is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
Narrowing post #36, because the general version has more than one answer.
Eating-disorder history is raised here regularly and is the case where the guidance most consistently says the decision needs specialist input.
I have separated what I observed from what I concluded, which does not always happen.
Where I have landed on Hypertension improvement, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.
Collapsed as off-topic by two members at trust level 3 or above
Taking post #40 at face value and following it one step further.
Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them.
None of the above is medical advice and I am not qualified to give any.
Post #38 and I disagree about the size of the effect, not about the direction.
A definition problem is doing most of the work in this Hypertension improvement discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Adding a data point of agreement rather than a data point.
Practical experience of Hypertension improvement, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.
Worth separating two things that post #42 runs together.
Eating-disorder history is raised here regularly and is the case where the guidance most consistently says the decision needs specialist input.
The general case is well covered; this is the awkward specific one.
An observation about Hypertension improvement that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
What I would check first on Hypertension improvement is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
Fair, and the limits you put on it are the part I will remember.
Everything in post #53 holds. The case it does not cover is the one I have.
Reading this Hypertension improvement thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.
I am describing what is, rather than arguing for what should be.
Whatever the answer on Hypertension improvement turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
This is the first time the answer has come with its own limits attached. Appreciated.
The arithmetic in post #57 is right; the assumption feeding it is the part to check.
Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.
Reading it again, the caveat matters more than the finding.